TSS
DYN icon

Two Sigma Securities’s Dyne Therapeutics DYN Stock Holding History

Two Sigma Securities’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+10,015
New +$186K 0.02% 1102
2025
Q3 		– Sell
-11,377
Closed -$108K – 1544
2025
Q2 		$108K Buy
+11,377
New +$125K 0.01% 1033

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Securities's DYN Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 10,015 shares worth $222K. The stake represents 0.02% of the portfolio and ranks #1102 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in DYN as recently as Q2 2025.

Two Sigma Securities first reported a position in DYN in Q2 2025 and has held it in 2 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Two Sigma Securities held 10,015 shares of Dyne Therapeutics worth $222K as of Q2 2026.
  • Dyne Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Dyne Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1102 holding.
  • Two Sigma Securities first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.